Keywords: monotherapy, filing, lamotrigine, uk, wellcome, applied, approval

Monotherapy Filing For Lamotrigine In UK

Article | 26 September 1994

Print This

Wellcome has applied for approval to market its anticonvulsant drug Lamictal (lamotrigine) for use as a monotherapy for adult epilepsy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in